Legal Archives - Page 3 of 6 - Boston Life Sciences Times

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

November 6, 2026

Two Cambridge MedTech Companies Named Finalists in MedTech Innovator’s 2026 Grand Prize Competition

November 5, 2026

Insulet Third-Quarter Profit Jumps 61% to $141.1 Million as Revenue Climbs to $842 Million

November 4, 2026

THIS WEEK'S STORIES

Seaport Therapeutics Reports $26.4 Million Third-Quarter Loss, Advances Depression and Anxiety Drug Trials

November 2, 2026

More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12

November 2, 2026

Thermo Fisher Scientific Launches Lower-Cost qPCR Master Mixes for Research Laboratories

November 5, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Law Firm Launches Investigation Into Boston Scientific Executives Following Stock Decline

Halozyme Wins European Patent Injunction Blocking Merck’s Keytruda SC in Eight Markets

Wisner Baum Attorneys Named to Leadership Roles in Boston Scientific Spinal Cord Stimulator Litigation

Class Action Filed Against Insulet Over Alleged Manufacturing Control Failures

Harvard Reaches $53 Million Settlement in Anatomical Gifts Scandal

Most Read

Agenus Reports 51% of Colorectal Cancer Patients Survived at Least 18 Months Following Experimental Immunotherapy

Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials

Tandem Diabetes Care Appoints Jeannette Bankes as CEO, Succeeding John Sheridan

Sarepta Therapeutics Narrows Third-Quarter Loss to $28.5 Million, Advances Rare Disease Drug Programs

EDITOR PICKS